$REPL
stock+ Make pickLast price
$12.86
Today
▲ 8.71%
Open
$11.78
Day range
$11.58 – $13.90
Volume
6.8M
52-wk range
$1.50 – $13.90
Avg target (2)
$12.80
Implied move
-0.5%
where the room's targets sit vs price
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 1 | Sarchi ChristopherChief Commercial Officer | Sell | −12.0K | $9.24 | $111K |
| May 18 | Xynos KonstantinosChief Medical Officer | Sell | −14.0K | $5.08 | $71.2K |
| May 18 | Schwendenman AndrewChief Accounting Officer | Sell | −7.9K | $5.08 | $40.1K |
| May 18 | Sarchi ChristopherChief Commercial Officer | Sell | −8.6K | $5.08 | $43.8K |
| May 18 | Astley-Sparke PhilipDirector | Sell | −17.7K | $5.08 | $89.7K |
| May 18 | Patel SushilDirector · Chief Executive Officer | Sell | −37.3K | $5.08 | $190K |
| May 18 | Hill Emily LuisaChief Financial Officer | Sell | −7.8K | $5.08 | $39.7K |
| Apr 1 | Sarchi ChristopherChief Commercial Officer | Grant | +50.0K | $0.00 | $0 |
| Apr 1 | Astley-Sparke PhilipDirector | Grant | +50.0K | $0.00 | $0 |
source: SEC EDGAR (Form 4 / 13D / 13G) · free
13D/13G = beneficial owners above 5%. A full institutional holdings table (13F) needs a quarterly bulk-ingest of every manager's filing — also free, planned next.